Author:
Kerwar S. S.,Ridge Susan C.,Landes M. Jane,Nolan Joseph C.,Oronsky Arnold L.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Toxicology,Pharmacology,Immunology
Reference20 articles.
1. G. Weissman, Early events in rheumatoid arthritis. InRheumatoid Arthritis, pp. 29–47 (Ed.E.D. Harris). Medcom Press, New York 1974.
2. J.M. Dayer, R.G.G. Russel andS.M. Krane,Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor, Science, N.Y.195, 181–183 (1977).
3. J.M. Dayer, S.M. Krane andS.R. Goldring,Consideration of possible cellular events in the destructive synovial lesion of rheumatoid arthritis, Adv. Inflam. Res.3, 1–23 (1982).
4. J.M. Dayer, S.B. Mizel, S.M. Krane andS.E. Mergenhagen,Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte activating factor (Interleukin I), Proc. natn. Acad. Sci. USA78, 2474–2479 (1981).
5. L.M. Wahl, S.M. Wahl, S.E. Mergenhagen andG.R. Martin,Collagenase production by lymphokine activated macrophages, Science, N.Y.187, 261–263 (1973).